Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008 Nov 1;33(4):475–482. doi: 10.1007/s12038-008-0066-z

Emerging influenza virus: A global threat

M Khanna 1,✉, P Kumar 1, K Choudhary 1, B Kumar 1, V K Vijayan 2
PMCID: PMC7101584  PMID: 19208973

Abstract

Since 1918, influenza virus has been one of the major causes of morbidity and mortality, especially among young children. Though the commonly circulating strain of the virus is not virulent enough to cause mortality, the ability of the virus genome to mutate at a very high rate may lead to the emergence of a highly virulent strain that may become the cause of the next pandemic. Apart from the influenza virus strain circulating in humans (H1N1 and H3N2), the avian influenza H5N1 H7 and H9 virus strains have also been reported to have caused human infections, H5N1 H7 and H9 have shown their ability to cross the species barrier from birds to humans and further replicate in humans. This review addresses the biological and epidemiological aspects of influenza virus and efforts to have a control on the virus globally.

Keywords: H1N1, H3N2, H5N1, influenza, pandemic

References

  1. Abed Y., Goyette N., Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 2005;49:556–559. doi: 10.1128/AAC.49.2.556-559.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Areechokchai D., Jiraphongsa C., Laosiritaworn Y., Hanshaoworakul W., O’Reilly M. Investigation of avian influenza (H5N1) outbreak in humans—Thailand, 2004. Morb. Mortal. Wkly Rep. 2006;55:3–6. [PubMed] [Google Scholar]
  3. Belshe R. B., Gruber W. C., Mendelman P. M., Mehata H. B., Mahmood K., Reisinger K., Treanor J., Zangwill K., et al. Correlates of imune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 2000;181:1133–1137. doi: 10.1086/315323. [DOI] [PubMed] [Google Scholar]
  4. Belshe R. B., Gruber W. C., Mendelman P. M., Cho I., Reisinger K., Block S. L., Wittes J., Iacuzio D., et al. Efficacy of vaccination with live atteuated, cold adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sidney) not contained in the vaccine. J. Pediatr. 2000;136:168–175. doi: 10.1016/S0022-3476(00)70097-7. [DOI] [PubMed] [Google Scholar]
  5. Belshe R. B., Smith H. M., Hall C. B., Betts R., Hay A. J. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 1988;62:1508–1512. doi: 10.1128/jvi.62.5.1508-1512.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bridges C. B., Lim W., Hu-Primmer J., Sims L., Fukuda K., Mak K. H., Rowe T., Thompson W. W., et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997–1998. J. Infect. Dis. 2002;185:1005–1010. doi: 10.1086/340044. [DOI] [PubMed] [Google Scholar]
  7. Brumback B. G., Wade C. D. Simultaneous rapid culture for four respiratory viruses in the same cell monolayer using a differential multicolored fluorescent confirmatory stain. J. Clin. Microbiol. 1996;34:798. doi: 10.1128/jcm.34.4.798-801.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Call S., Vollenweider M., Hornung C., Simel D., McKinney W. Does this patient have influenza? JAMA. 2005;293:987. doi: 10.1001/jama.293.8.987. [DOI] [PubMed] [Google Scholar]
  9. Davies F. G., Casals J., Jesset D. M., Ochieng P. The serological relationships of Nairobi sheep disease virus. J. Comp. Pathol. 1978;88:519. doi: 10.1016/0021-9975(78)90005-1. [DOI] [PubMed] [Google Scholar]
  10. Demicheli V., Jefferson T., Rivet D., Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine. 2000;18:957–1030. doi: 10.1016/S0264-410X(99)00332-1. [DOI] [PubMed] [Google Scholar]
  11. Dinh P. N., Long H. T., Tien N. T., Hien N. T., et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg. Infect. Dis. 2006;12:1841–1847. doi: 10.3201/eid1212.060829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dunnil P. A. DNA flu vaccine in practice. Nat. Biotechnol. 2006;24:139. doi: 10.1038/nbt0206-139a. [DOI] [PubMed] [Google Scholar]
  13. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 2005;5:718. doi: 10.1016/S1473-3099(05)70270-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Elveback L. R., Fox J. P., Ackerman E. An influenza simulation model for immunization studies. Am. J. Epidemiology. 1976;103:152. doi: 10.1093/oxfordjournals.aje.a112213. [DOI] [PubMed] [Google Scholar]
  15. Gubareva L. V., McCullers J. A., Bethell R. C., Webster R. G. Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. J. Infect. Dis. 1998;178:1592. doi: 10.1086/314515. [DOI] [PubMed] [Google Scholar]
  16. Hayden F. G., Hay A. J. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol. 1992;176:119–130. doi: 10.1007/978-3-642-77011-1_8. [DOI] [PubMed] [Google Scholar]
  17. Hilleman M. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine. 2002;20:3068–3087. doi: 10.1016/S0264-410X(02)00254-2. [DOI] [PubMed] [Google Scholar]
  18. Hirst G. K. Agglutination of red cells by amniotic fluid of chick embryos infected with influenza virus. Science. 1941;94:22. doi: 10.1126/science.94.2427.22. [DOI] [PubMed] [Google Scholar]
  19. Hoffmann E., Mahmood K., Chen Z., Yang C.-F., Spaete J., Greenberg H. B., Herlocher M. L., Jin H., Kemble G. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/ 1/66. J. Virol. 2005;79:11014–11021. doi: 10.1128/JVI.79.17.11014-11021.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hui D. C. Influenza A/H5N1 infection: Other treatment options and issues. Respirology. 2008;13:S22–S26. doi: 10.1111/j.1440-1843.2008.01250.x. [DOI] [PubMed] [Google Scholar]
  21. Hui D. S. C. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology. 2008;13:S10–S13. doi: 10.1111/j.1440-1843.2008.01247.x. [DOI] [PubMed] [Google Scholar]
  22. Jin H., Lu B., Zhou H., Ma C., Zhao J., Yang C. F., Kenble G., Greenberg H. Multiple amino acid residues confer temperature sensitivity to influenza virus vaccine strains (FluMist) derived from cold adapted A/Ann Arbor/ 6/60. Virology. 2003;306:18–24. doi: 10.1016/S0042-6822(02)00035-1. [DOI] [PubMed] [Google Scholar]
  23. Kandun I. N., Wibisono H., Sedyaningsih E. R., Yusharmen, Hadisoedarsuno W., Purba W., Santoso H., Septiawati C., et al. Three Indonesian clusters of H5N1 virus infection in 2005. N. Engl. J. Med. 2006;355:2186–2194. doi: 10.1056/NEJMoa060930. [DOI] [PubMed] [Google Scholar]
  24. Kawaoka Y., Krauss S., Webster R. G. Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 1989;63:4603. doi: 10.1128/jvi.63.11.4603-4608.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaneko H., Kawana T., Fukushima E., Suzutani T. Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J. Biochem. Biophys. Methods. 2007;70:499. doi: 10.1016/j.jbbm.2006.08.008. [DOI] [PubMed] [Google Scholar]
  26. Kerr A. A., McQuillin J., Downham M. A., Gardner P. S. Gastric flu influenza B causing abdominal symptons in children. Lancet. 1975;1:291. doi: 10.1016/S0140-6736(75)91205-2. [DOI] [PubMed] [Google Scholar]
  27. Khanna M., Kumar P. Influenza: A serious global threat. J. Infect. Dis. Antimicro Agents. 2002;19:25. [Google Scholar]
  28. Khanna M., Srivastava V. Clinical laboratory diagnosis of influenza. Adv. Med. Veter. Virol. Immunol. Epidemiol. 2006;6:138. [Google Scholar]
  29. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (London) 1991;352:77. doi: 10.1038/352077a0. [DOI] [PubMed] [Google Scholar]
  30. Lee C. W., Suarez D. L. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J. Virol. Methods. 2004;119:151. doi: 10.1016/j.jviromet.2004.03.014. [DOI] [PubMed] [Google Scholar]
  31. Mathew T. M. Epidemiology of influenza A, B and C. Adv. Med. Veter. Virol. Immunol. Epidemiol. 2006;6:24. [Google Scholar]
  32. McElhaney J., Beattie B. L., Devin R., Grynoch R., Toth E. L., Bleackely R. C. Age related decline in interleukin 2 production in response to influenza vaccine. J. Am. Geriatr. Soc. 1990;38:652–658. doi: 10.1111/j.1532-5415.1990.tb01424.x. [DOI] [PubMed] [Google Scholar]
  33. Ministry of Health. U K 1920 Report on the pandemic of influenza, 1918–19; Rep. Health Med. Subjects4 182
  34. Monto A. S., Robinson D. P., Herlocher M. L., Hinson J. M., Elliott M. J., Crisp A. Zanamivir in the prevention of influenza among healthy adults. JAMA. 1999;282:31–35. doi: 10.1001/jama.282.1.31. [DOI] [PubMed] [Google Scholar]
  35. Olsen S. J., Ungchusak K., Sovann L., Uyeki T. M., Dowell S. F., Cox N. J., Aldis W., Chunsuttiwat S. Family clustering of avian influenza A (H5N1) Emerg. Infect. Dis. 2005;11:1799–801. doi: 10.3201/eid1111.050646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Orskov I., Orskov F. Serologic classification of fimbriae. Curr. Top. Microbiol. Immunol. 1990;151:71. [PubMed] [Google Scholar]
  37. Osterholm M. T. Preparing for the next pandemic. N. Engl. J. Med. 2005;352:1839. doi: 10.1056/NEJMp058068. [DOI] [PubMed] [Google Scholar]
  38. Palese P. Influenza: Old and new threats. Nat. Med. 2004;10:S82. doi: 10.1038/nm1141. [DOI] [PubMed] [Google Scholar]
  39. Poon L. L. M., Leung C. S. W., Chan K. H., Lee J. H. C., Yuen K. Y., Guan Y., Peiris J. S. M. Detection of human influenza A viruses by loop-mediated isothermal amplification. J. Clin. Microbiol. 2005;43:427. doi: 10.1128/JCM.43.1.427-430.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ridley R. G. Research on infectious diseases requires better coordination. Nat. Med. 2004;10:S137. doi: 10.1038/nm1153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schmitz N., Kurrer M., Bachmann M., Kopf M. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J. Virol. 2005;79:6441. doi: 10.1128/JVI.79.10.6441-6448.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sedyaningsih E. R., Isfandari S., Setiawaty V., Rifati L., Harun S., Purba W., Blair P. J., Putman S. D., et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005–June 2006. J. Infect. Dis. 2007;196:522–527. doi: 10.1086/519692. [DOI] [PubMed] [Google Scholar]
  43. Stephenson I., Nicholson K. G., Wood J. M., Zambon M. C., Katz J. M. Confronting the avian influenza threat; vaccine development for a potential pandemic. Lancet. 2004;4:499. doi: 10.1016/S1473-3099(04)01105-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stockton J., Ellis J. S., Saville M., Clewley J. P., Zambon M. C. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J. Clin. Microbiol. 1998;36:2990. doi: 10.1128/jcm.36.10.2990-2995.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tambyah P.A. Update on influenza vaccines. Respirology. 2008;13:S41–S43. doi: 10.1111/j.1440-1843.2008.01257.x. [DOI] [PubMed] [Google Scholar]
  46. Trani L. D., Bedini B., Donatelli I., Campitelli L., Chiappini B., Marco M. A., Delogu M., Buonavoglia C., Vaccari G. A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control. BMC Infect. Dis. 2006;6:87. doi: 10.1186/1471-2334-6-87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Puthaathana P., Uipraserkul M., Boonnak K., et al. Probable person-to-person transmission of avian influenza A (H5N1) N. Engl. J. Med. 2005;352:333–340. doi: 10.1056/NEJMoa044021. [DOI] [PubMed] [Google Scholar]
  48. Wang C., Takeuchi K., Pinto L. H., Lamb R. A. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 1993;67:5585. doi: 10.1128/jvi.67.9.5585-5594.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Webby R. J., Webster R. G. Are we ready for pandemic influenza? Science. 2003;302:1519. doi: 10.1126/science.1090350. [DOI] [PubMed] [Google Scholar]
  50. World Health Organization 2005 Avian influenza: Assessing the pandemic threat (Geneva)
  51. World Health Organization 2007 Clinical management of human infection with avian influenza A (H5N1) virus. Updated advice 15 August available from http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf
  52. World Health Organization 2006 Recommendations and laboratory procedures for detection of avian influenza A (H5N1) virus in specimens from suspected human cases. available from http://www.who.int/csr/disease/avian_influenza/guidelines/RecAIlabtestsAug07pdf
  53. World Health Organization 2008 Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO — available from URL: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2008_01_11/en/print.html
  54. World Health Organization. Update WHO-confirmed human cases of avian influenza A (H5N1) infection. Wkly. Epidemiol. Rec. 2007;82:41–47. [Google Scholar]
  55. Wright K. E., Wilson G. A. R., Novosad D., Dimock C., Tan D., Weber J. M. Typing and subtyping of influenza viruses in clinical samples by PCR. J. Clin. Microbiol. 1995;33:1180–1184. doi: 10.1128/jcm.33.5.1180-1184.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Writing committee of the second World Health Organization Consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 2008;358:261–73. doi: 10.1056/NEJMra0707279. [DOI] [PubMed] [Google Scholar]
  57. Uyeki T. M. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology. 2008;13:S2–S9. doi: 10.1111/j.1440-1843.2008.01246.x. [DOI] [PubMed] [Google Scholar]
  58. Yu H., Feng Z., Zhang X., Xiang N., Huai Y., Zhou L. Human influenza A (H5N1) cases, urban areas of people’s Republic of China, 2005–2006. Emerg. Infect. Dis. 2007;13:1061–1065. doi: 10.3201/eid1307.061557. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Biosciences are provided here courtesy of Nature Publishing Group

RESOURCES